A Japanese lung cancer registry study at 2002

Noriyoshi Sawabata, Hisao Asamura, Tomoyuki Goya, Masaki Mori, Yoichi Nakanishi, Kenji Eguchi, Yoshihiko Koshiishi, Ryosuke Tsuchiya, Meinoshin Okumura, Etsuo Miyaoka, Yoshitaka Fujii

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVES: To publicize clinical results of Japanese lung cancer patients registered in 2002. Study design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. RESULTS: There were two times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non-small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.7% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. CONCLUSION: An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

Original languageEnglish
Pages (from-to)333-344
Number of pages12
JournalNihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
Volume48
Issue number4
Publication statusPublished - 2010 Apr
Externally publishedYes

Fingerprint

Small Cell Carcinoma
Registries
Lung Neoplasms
Squamous Cell Carcinoma
Histology
Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
Observational Studies
Adenocarcinoma
Survival Rate
Prospective Studies
Carcinoma
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sawabata, N., Asamura, H., Goya, T., Mori, M., Nakanishi, Y., Eguchi, K., ... Fujii, Y. (2010). A Japanese lung cancer registry study at 2002. Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, 48(4), 333-344.

A Japanese lung cancer registry study at 2002. / Sawabata, Noriyoshi; Asamura, Hisao; Goya, Tomoyuki; Mori, Masaki; Nakanishi, Yoichi; Eguchi, Kenji; Koshiishi, Yoshihiko; Tsuchiya, Ryosuke; Okumura, Meinoshin; Miyaoka, Etsuo; Fujii, Yoshitaka.

In: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, Vol. 48, No. 4, 04.2010, p. 333-344.

Research output: Contribution to journalArticle

Sawabata, N, Asamura, H, Goya, T, Mori, M, Nakanishi, Y, Eguchi, K, Koshiishi, Y, Tsuchiya, R, Okumura, M, Miyaoka, E & Fujii, Y 2010, 'A Japanese lung cancer registry study at 2002', Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, vol. 48, no. 4, pp. 333-344.
Sawabata, Noriyoshi ; Asamura, Hisao ; Goya, Tomoyuki ; Mori, Masaki ; Nakanishi, Yoichi ; Eguchi, Kenji ; Koshiishi, Yoshihiko ; Tsuchiya, Ryosuke ; Okumura, Meinoshin ; Miyaoka, Etsuo ; Fujii, Yoshitaka. / A Japanese lung cancer registry study at 2002. In: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2010 ; Vol. 48, No. 4. pp. 333-344.
@article{b1e0b4f598864f12aaa615e1ad49dcd2,
title = "A Japanese lung cancer registry study at 2002",
abstract = "OBJECTIVES: To publicize clinical results of Japanese lung cancer patients registered in 2002. Study design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. RESULTS: There were two times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7{\%}, following squamous cell carcinoma in 25.7{\%} and small cell carcinoma in 9.2{\%}. Clinical stage was IA in 29.3{\%}, IB in 15.3{\%}, IIA in 1.4{\%}, IIB in 6.2{\%}, IIIA in 11.8{\%}, IIIB in 14.6{\%} and IV in 21.0{\%}. Surgery was performed in 8454 cases (57.5{\%}). Five-year survival rate was 44.3{\%} for all patients, 14.7{\%} for cases of small cell carcinoma, 46.8{\%} for non-small cell carcinoma, 59.6{\%} for surgery cases, 8.5{\%} for no surgery cases, 37.7{\%} for males and 59.0{\%} for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7{\%} and 79.4{\%} for IA, 39.3{\%} and 56.7{\%} for IB, 31.7{\%} and 49.0{\%} for IIA, 29.9{\%} and 42.3{\%} for IIB, 17.2{\%} and 30.9{\%} for IIIA, 12.4{\%} and 16.7{\%} for IIIB and 3.8{\%} and 5.8{\%} for IV, respectively. CONCLUSION: An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.",
author = "Noriyoshi Sawabata and Hisao Asamura and Tomoyuki Goya and Masaki Mori and Yoichi Nakanishi and Kenji Eguchi and Yoshihiko Koshiishi and Ryosuke Tsuchiya and Meinoshin Okumura and Etsuo Miyaoka and Yoshitaka Fujii",
year = "2010",
month = "4",
language = "English",
volume = "48",
pages = "333--344",
journal = "Respiratory Investigation",
issn = "2212-5345",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - A Japanese lung cancer registry study at 2002

AU - Sawabata, Noriyoshi

AU - Asamura, Hisao

AU - Goya, Tomoyuki

AU - Mori, Masaki

AU - Nakanishi, Yoichi

AU - Eguchi, Kenji

AU - Koshiishi, Yoshihiko

AU - Tsuchiya, Ryosuke

AU - Okumura, Meinoshin

AU - Miyaoka, Etsuo

AU - Fujii, Yoshitaka

PY - 2010/4

Y1 - 2010/4

N2 - OBJECTIVES: To publicize clinical results of Japanese lung cancer patients registered in 2002. Study design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. RESULTS: There were two times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non-small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.7% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. CONCLUSION: An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

AB - OBJECTIVES: To publicize clinical results of Japanese lung cancer patients registered in 2002. Study design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. RESULTS: There were two times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non-small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.7% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. CONCLUSION: An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

UR - http://www.scopus.com/inward/record.url?scp=77952761080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952761080&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 333

EP - 344

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - 4

ER -